A driving force in thyroid cancer research and treatment, Dr. Haugen is an endocrinologist and physician-scientist who has published extensively on the applications of thyroid molecular testing.

Dr. Haugen is a past president of the American Thyroid Association and recipient of the 2012 Paul Starr Award and 2019 Sidney Ingbar Award from the American Thyroid Association and the 2023 Outstanding Scholarly Physician Award from the Endocrine Society.

Over the past 30 years, Dr. Haugen has made significant contributions to the diagnosis and treatment of thyroid neoplasms, including the development of guidelines for the management of patients with thyroid nodules and differentiated thyroid cancer.

As Clinical Liaison of ThyroSeq Program, Sonic Healthcare USA, Dr. Haugen serves as a bridge between the ThyroSeq molecular testing program and the medical community with a focus on educational outreach. He is available for direct consultation by interested clinicians.



Dr. La Greca is an endocrinologist specializing in treatment of thyroid nodules, thyroid cancer and other thyroid disorders. She is an Associate Professor of Medicine in the Division of Endocrinology, Metabolism and Diabetes, and she also serves as the Director of the Thyroid Oncology Program at the University of Colorado Anschutz.

She is part of the UCHealth Thyroid Cancer Multidisciplinary Clinic at the Anschutz Medical Campus, as well as an active member of the American Thyroid Association, Endocrine Society, American Association of Clinical Endocrinologists and the International Thyroid Oncology Group.

She received her medical degree from the University of Buenos Aires, completed her residency at Yale-New Haven Medical Center in Connecticut and completed one fellowship in endocrinology, diabetes and metabolism at the University of Oklahoma Health Sciences Center Program and another in thyroid cancer at Memorial Sloan Kettering Cancer Center.

Dr. Nikiforov is a world expert on thyroid pathology and the molecular mechanisms of thyroid cancer. At UPMC, he serves as Vice-Chair for Molecular Pathology, is Director of the Division of Molecular and Genomic Pathology, oversees the operations of the Molecular and Genomic Pathology laboratory and is the Co-Director of the Multidisciplinary Thyroid Center.

He is one of the inventors of the ThyroSeq® thyroid molecular test.  He has published over 250 peer-reviewed articles, and he is a senior editor of the textbook Diagnostic Pathology and Molecular Genetics of the Thyroid. His research program is focused on molecular mechanisms of thyroid cancer, radiation carcinogenesis, and molecular diagnostics. In 2016, he led an international group of physicians and scientists to reclassify a type of thyroid cancer as a non-cancer called NIFTP, which prevented a cancer diagnosis and reduced overtreatment for thousands of patients worldwide.

He is an elected member of the American Society for Clinical Investigation and a recipient of the 2007 Van Meter Award, the 2017 Sidney H. Ingbar Distinguished Lectureship Award from the American Thyroid Association, and the 2016 Aldo Pinchera Award from the Italian Thyroid Carcinoma Observatory. He has served as part of the American Thyroid Association task forces that developed the 2012 and 2021 Guidelines for Management of Patients with Anaplastic Thyroid Cancer and the 2015 Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer.